Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Closed Research Teams
  • View item
  • Home
  • ICR Divisions
  • Closed Research Teams
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Typical medullary breast carcinomas have a basal/myoepithelial phenotype

Thumbnail
Date
2005-11
ICR Author
Lakhani, Sunil
Author
Jacquemier, J
Padovani, L
Rabayrol, L
Lakhani, SR
Penault-Llorca, F
Denoux, Y
Fiche, M
Figueiro, P
Maisongrosse, V
Ledoussal, V
Penuela, JM
Udvarhely, N
El Makdissi, G
Ginestier, C
Geneix, J
Charafe-Jauffret, E
Xerri, L
Eisinger, F
Birnbaum, D
Scree, EWGB
Hag, BCLC
Show allShow less
Type
Journal Article
Metadata
Show full item record
Abstract
Medullary breast cancer (MBC) is a rare, diagnostically difficult, pathological subtype. Despite being high grade, it has a good prognosis. MBC patients have an excess of BRCA1 germ-fine mutation and reliable identification of MBC could help to identify patients at risk of carrying germline BRCA1 mutations or in whom chemotherapy could be avoided. The aim of this study was therefore to improve diagnosis by establishing an MBC protein expression profile using immunohistochemistry (IHC) on tissue-microarrays (TMA). Using a series of 779 breast carcinomas (’EC’ set), diagnosed initially as MBC, a double-reading session was carried out by several pathologists on all of the histological material to establish the diagnosis as firmly as possible using a ‘medullary score’. Only MBCs with high scores, i.e. typical MBC (TMBC) (n = 44) and non-TMBC grade III with no or low scores (n = 160), were included in the IHC study. To validate the results obtained on this first set, a control series of TMBC (n = 17) and non-MBC grade III cases (n = 140) (’IPC’ set) was studied. The expression of 18 proteins was studied in the 61 TMBCs and 300 grade III cases from the two sets. The global intra-observer concordance of the first reading for the diagnosis of TMBC was 94%, with almost perfect kappa (kappa) of 0.815. TMBC was characterized by a high degree of basal/myoepithelial differentiation. In multivariate analysis with logistic regression, TMBC was defined by the association of P-cadherin (R = 2.29), MIB1 > 50 (R = 3.80), ERBB2 negativity (R = 2.24) and p53 positivity (RR = 1.45). Copyright (c) 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
URI
https://repository.icr.ac.uk/handle/internal/2563
DOI
https://doi.org/10.1002/path.1845
Collections
  • Closed Research Teams
Research team
Molecular Pathology
Language
eng
License start date
2005-11
Citation
JOURNAL OF PATHOLOGY, 2005, 207 pp. 260 - 268
Publisher
JOHN WILEY & SONS LTD

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.